Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI


Primary Symbol: V.BTI.H Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(2146)
•••
Comment by jdstoxon Jun 05, 2020 2:28pm
117 Views
Post# 31117692

RE:RE:RE:RE:RE:Sure is being pinned down...

RE:RE:RE:RE:RE:Sure is being pinned down...The 1.1 million shares sold through National Bank was the expression of an opinion by one person. A general opinion expressed about a stock based on the opinion of one person is pretty much a worthless opinion.

About not wanting "...to see National Bank and whoever else has been selling get another cheap financing," well, you're a capitalist (I assume), digitel, and our experience is that you know exactly how to profit from that. You'll help scare the price down, buy some and then profit when the stock comes back after a financing.

You're kind of a creep that way, digitel, but the thing about any game is that if we understand it, we can play it better. We all know your game, digitel.

But it is kind of precious that you would wring your hands and say, "I just don't want to see..."

You don't have an altruistic bone in your body, digitel. Everything you post is for the promotion of your own interests.

jdstox

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities